Construction of a pharmaceutical care mode for cancer pain patients in primary care based on the Delphi method: an effective analysis
Objective: Pain is one of the most common symptoms of cancer patients. Patients with advanced stages of cancer are always transferred to primary medical institutions or treated with home medication due to their specific pathophysiological characteristics. Studies have shown that continuous pharmaceu...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-11-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1268793/full |
| _version_ | 1797491334149308416 |
|---|---|
| author | Han Xie Xinyi Chen Min Xue Huaying Li Yonghan Ge Weihong Ge Weihong Ge |
| author_facet | Han Xie Xinyi Chen Min Xue Huaying Li Yonghan Ge Weihong Ge Weihong Ge |
| author_sort | Han Xie |
| collection | DOAJ |
| description | Objective: Pain is one of the most common symptoms of cancer patients. Patients with advanced stages of cancer are always transferred to primary medical institutions or treated with home medication due to their specific pathophysiological characteristics. Studies have shown that continuous pharmaceutical care can improve the effectiveness and safety of drug therapy for cancer pain patients in primary care, but no relevant research has been conducted in China. Based on the Delphi method, this study aims to construct a pharmaceutical care mode for cancer pain patients and analyze its effect in drug therapy treatment in primary care in China.Methods: A pharmaceutical care mode for cancer pain patients in primary care was developed through two rounds of expert consensus. A total of 200 cancer pain patients from January 2022 to January 2023 in Nanjing Drum Tower Hospital were recruited and divided into an intervention group and control group. The self-developed pharmaceutical care mode in primary care was conducted in the intervention group, while the traditional pharmaceutical care mode was conducted in the control group. Comparisons between the groups were performed in terms of pain assessment rate, reasonable rate of pain assessment, pain score, and incidence of adverse reactions.Results: The initiative of experts in the two rounds of consultation was 100%, with an authority coefficient of 0.83. The coordination coefficient of the second round was higher than that of the first round, indicating that the consistency of expert opinions was enhanced. There were 100 cases in each group, and 12 and 8 were lost to follow-up in the intervention group and control group, respectively. Compared with the control group, the intervention group had a significantly higher pain assessment rate, a reasonable rate of pain assessment, and a significantly lower pain score and incidence of adverse reactions.Conclusion: Under the scientific and reasonable mode of pharmaceutical care for cancer pain patients at the primary level, standardized drug therapy could significantly enhance the efficacy of treatment, thereby improving the quality of life of patients. |
| first_indexed | 2024-03-10T00:46:01Z |
| format | Article |
| id | doaj.art-49a99d0d499849459c4041e608d6dc29 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-03-10T00:46:01Z |
| publishDate | 2023-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-49a99d0d499849459c4041e608d6dc292023-11-23T14:59:11ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-11-011410.3389/fphar.2023.12687931268793Construction of a pharmaceutical care mode for cancer pain patients in primary care based on the Delphi method: an effective analysisHan Xie0Xinyi Chen1Min Xue2Huaying Li3Yonghan Ge4Weihong Ge5Weihong Ge6Department of Pharmacy, Nanjing Drum Tower Hospital, Nanjing, Jiangsu, ChinaDepartment of Pharmacy, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, Jiangsu, ChinaDepartment of Pharmacy, Nanjing Drum Tower Hospital, Nanjing, Jiangsu, ChinaDepartment of Pharmacy, Nanjing Yuhuatai District Xishanqiao Community Health Service Center, Nanjing, Jiangsu, ChinaDepartment of Pharmacy, Nanjing Drum Tower Hospital, Nanjing, Jiangsu, ChinaDepartment of Pharmacy, Nanjing Drum Tower Hospital, Nanjing, Jiangsu, ChinaDepartment of Pharmacy, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, Jiangsu, ChinaObjective: Pain is one of the most common symptoms of cancer patients. Patients with advanced stages of cancer are always transferred to primary medical institutions or treated with home medication due to their specific pathophysiological characteristics. Studies have shown that continuous pharmaceutical care can improve the effectiveness and safety of drug therapy for cancer pain patients in primary care, but no relevant research has been conducted in China. Based on the Delphi method, this study aims to construct a pharmaceutical care mode for cancer pain patients and analyze its effect in drug therapy treatment in primary care in China.Methods: A pharmaceutical care mode for cancer pain patients in primary care was developed through two rounds of expert consensus. A total of 200 cancer pain patients from January 2022 to January 2023 in Nanjing Drum Tower Hospital were recruited and divided into an intervention group and control group. The self-developed pharmaceutical care mode in primary care was conducted in the intervention group, while the traditional pharmaceutical care mode was conducted in the control group. Comparisons between the groups were performed in terms of pain assessment rate, reasonable rate of pain assessment, pain score, and incidence of adverse reactions.Results: The initiative of experts in the two rounds of consultation was 100%, with an authority coefficient of 0.83. The coordination coefficient of the second round was higher than that of the first round, indicating that the consistency of expert opinions was enhanced. There were 100 cases in each group, and 12 and 8 were lost to follow-up in the intervention group and control group, respectively. Compared with the control group, the intervention group had a significantly higher pain assessment rate, a reasonable rate of pain assessment, and a significantly lower pain score and incidence of adverse reactions.Conclusion: Under the scientific and reasonable mode of pharmaceutical care for cancer pain patients at the primary level, standardized drug therapy could significantly enhance the efficacy of treatment, thereby improving the quality of life of patients.https://www.frontiersin.org/articles/10.3389/fphar.2023.1268793/fullcancer painpharmaceutical careDelphi methodpain managementprimary care |
| spellingShingle | Han Xie Xinyi Chen Min Xue Huaying Li Yonghan Ge Weihong Ge Weihong Ge Construction of a pharmaceutical care mode for cancer pain patients in primary care based on the Delphi method: an effective analysis Frontiers in Pharmacology cancer pain pharmaceutical care Delphi method pain management primary care |
| title | Construction of a pharmaceutical care mode for cancer pain patients in primary care based on the Delphi method: an effective analysis |
| title_full | Construction of a pharmaceutical care mode for cancer pain patients in primary care based on the Delphi method: an effective analysis |
| title_fullStr | Construction of a pharmaceutical care mode for cancer pain patients in primary care based on the Delphi method: an effective analysis |
| title_full_unstemmed | Construction of a pharmaceutical care mode for cancer pain patients in primary care based on the Delphi method: an effective analysis |
| title_short | Construction of a pharmaceutical care mode for cancer pain patients in primary care based on the Delphi method: an effective analysis |
| title_sort | construction of a pharmaceutical care mode for cancer pain patients in primary care based on the delphi method an effective analysis |
| topic | cancer pain pharmaceutical care Delphi method pain management primary care |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2023.1268793/full |
| work_keys_str_mv | AT hanxie constructionofapharmaceuticalcaremodeforcancerpainpatientsinprimarycarebasedonthedelphimethodaneffectiveanalysis AT xinyichen constructionofapharmaceuticalcaremodeforcancerpainpatientsinprimarycarebasedonthedelphimethodaneffectiveanalysis AT minxue constructionofapharmaceuticalcaremodeforcancerpainpatientsinprimarycarebasedonthedelphimethodaneffectiveanalysis AT huayingli constructionofapharmaceuticalcaremodeforcancerpainpatientsinprimarycarebasedonthedelphimethodaneffectiveanalysis AT yonghange constructionofapharmaceuticalcaremodeforcancerpainpatientsinprimarycarebasedonthedelphimethodaneffectiveanalysis AT weihongge constructionofapharmaceuticalcaremodeforcancerpainpatientsinprimarycarebasedonthedelphimethodaneffectiveanalysis AT weihongge constructionofapharmaceuticalcaremodeforcancerpainpatientsinprimarycarebasedonthedelphimethodaneffectiveanalysis |